Biohaven Pharmaceuticals

5 followers

‌

Biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system.

Industries

Biotechnology

Headquarters

New Haven, United States

Employees

501-1,000

Links

Org chart

Warren Volles

General Counsel & Chief Legal Officer

George Clark

VP, Chief Accounting Officer

Robert Croop

Chief Development Officer, Neurology

Bruce D. Car

Chief Scientific Officer

Tova Gardin

Chief Translational Officer

Cliff Bechtold

President & GM, Biohaven Ireland, Chief Compliance Officer

Matthew Buten

Chief Financial Officer

Elyse Stock

Senior Scientific Advisor

St John Donnie McGrath

Chief of Corporate Strategy & Business Development

David Stock

VP, Biostatistics

Michael Bozik

President, Ion Channel Research & Development

Melissa Beiner

Director, R&D

Wes Kazmierski

Senior Director, Chemistry

Katy Mcgrath

Principal Scientist, In Vivo Science

David Weaver

SVP, Neuroscience & Pharmacology

Teams

+40

Leadership Team

43 members

+36

Clinical Operations Team

39 members

+26

Research and Development Team

29 members

Legal and Compliance Team

7 members

Similar companies

Immunome

2 followers

Amgen

201 followers

Neurocrine Biosciences

5 followers

KBI Biopharma

5 followers

Insmed

4 followers

Federal Housing Finance Agency

4 followers

Cytokinetics

11 followers

NeoGenomics

8 followers

4D Molecular Therapeutics

3 followers

BridgeBio

2 followers

Charles River Development

4 followers

Explore companies